Archive: 23/03/2017

Bavencio approved for rare skin cancer

(HealthDay)—Bavencio (avelumab) has been approved by the U.S. Food and Drug Administration to treat a rare but aggressive form of skin cancer called Merkel cell carcinoma (MCC), the agency said Thursday in a news release.

Mar 23, 2017
popularity0 comments 0